open access

Vol 61, No 1 (2010)
Original paper
Submitted: 2013-02-15
Published online: 2010-03-04
Get Citation

Cilazapril increases plasma ghrelin concentration in obese patients with arterial hypertension

Aleksander Skoczylas, Marcin Adamczak, Jerzy Chudek, Andrzej Więcek
Endokrynol Pol 2010;61(1):21-27.

open access

Vol 61, No 1 (2010)
Original Paper
Submitted: 2013-02-15
Published online: 2010-03-04

Abstract


Introduction: Ghrelin is a polypeptide hormone secreted mainly by the stomach cells, stimulating food intake and growth hormone release. Decreased plasma ghrelin concentration was found in obese subjects. Clinical and experimental data suggest that ghrelin also exerts a blood pressure lowering property. The influence of antihypertensive medication on plasma ghrelin concentration has not been studied, yet.
Material and methods: Plasma ghrelin concentration was estimated in 52 hypertensive obese (HA + O), 14 normotensive obese (O), and 15 lean healthy subjects in the fasting state, and after ingestion of a standard meal. HA + O patients were randomly allocated into 4 groups treated alternatively with: cilazapril, bisoprolol, amlodipine, or indapamide. After 6 weeks of antihypertensive monotherapy, the assessments were repeated.
Results: Similar fasting [HA + O - 780 (676-960) pg/ml; O - 751 (619-899) pg/ml] and postprandial plasma ghrelin concentrations were found in hypertensive and normotensive obese subjects. Plasma ghrelin concentrations in lean healthy subjects were significantly higher (987 (765-1366) pg/ml) in comparison to O and HA + O. Treatment with cilazapril was followed by a 28.0% increase of plasma ghrelin concentration (p = 0.04), while with bisoprolol, a 18.9% decrease (p = 0.01). No significant changes of ghrelinaemia were observed in HA + O treated with amlodipine or indapamide. No significant correlation between blood pressure and plasma ghrelin concentration before the therapy and their changes after 6 weeks of medication were found.
Conclusions:
1. Our data do not support the major role of ghrelin in blood pressure regulation in obesity.
2. An increase of plasma ghrelin concentration after treatment with cilazapril was observed.
(Pol J Endocrinol 2010; 61 (1): 21-27)

Abstract


Introduction: Ghrelin is a polypeptide hormone secreted mainly by the stomach cells, stimulating food intake and growth hormone release. Decreased plasma ghrelin concentration was found in obese subjects. Clinical and experimental data suggest that ghrelin also exerts a blood pressure lowering property. The influence of antihypertensive medication on plasma ghrelin concentration has not been studied, yet.
Material and methods: Plasma ghrelin concentration was estimated in 52 hypertensive obese (HA + O), 14 normotensive obese (O), and 15 lean healthy subjects in the fasting state, and after ingestion of a standard meal. HA + O patients were randomly allocated into 4 groups treated alternatively with: cilazapril, bisoprolol, amlodipine, or indapamide. After 6 weeks of antihypertensive monotherapy, the assessments were repeated.
Results: Similar fasting [HA + O - 780 (676-960) pg/ml; O - 751 (619-899) pg/ml] and postprandial plasma ghrelin concentrations were found in hypertensive and normotensive obese subjects. Plasma ghrelin concentrations in lean healthy subjects were significantly higher (987 (765-1366) pg/ml) in comparison to O and HA + O. Treatment with cilazapril was followed by a 28.0% increase of plasma ghrelin concentration (p = 0.04), while with bisoprolol, a 18.9% decrease (p = 0.01). No significant changes of ghrelinaemia were observed in HA + O treated with amlodipine or indapamide. No significant correlation between blood pressure and plasma ghrelin concentration before the therapy and their changes after 6 weeks of medication were found.
Conclusions:
1. Our data do not support the major role of ghrelin in blood pressure regulation in obesity.
2. An increase of plasma ghrelin concentration after treatment with cilazapril was observed.
(Pol J Endocrinol 2010; 61 (1): 21-27)
Get Citation

Keywords

ghrelin; obesity; arterial hypertension; cilazapril; antihypertensive therapy

About this article
Title

Cilazapril increases plasma ghrelin concentration in obese patients with arterial hypertension

Journal

Endokrynologia Polska

Issue

Vol 61, No 1 (2010)

Article type

Original paper

Pages

21-27

Published online

2010-03-04

Page views

694

Article views/downloads

1709

Bibliographic record

Endokrynol Pol 2010;61(1):21-27.

Keywords

ghrelin
obesity
arterial hypertension
cilazapril
antihypertensive therapy

Authors

Aleksander Skoczylas
Marcin Adamczak
Jerzy Chudek
Andrzej Więcek

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl